If you've been priced out of GLP-1 medications, Foundayo (orforglipron) might change the math. Eli Lilly launched Foundayo with aggressive pricing designed to undercut the competition — and it shows. Here's a complete breakdown of what Foundayo costs in every scenario.
Self-Pay Pricing (No Insurance)
Foundayo's self-pay pricing through retail pharmacies:
- 0.8mg (starting dose): ~$149/month
- Higher doses: Pricing increases with dose; Eli Lilly has not published the full price ladder as of April 2026
Important note: The $149/month price is confirmed for the lowest dose only. Do not assume this price applies to all doses — higher doses will cost more.
These prices are for a 30-day supply at retail pharmacies. Prices may vary slightly by pharmacy and location, but Eli Lilly has committed to keeping the list price accessible. You can verify current pricing at Foundayo.com or through your pharmacy.
Why is Foundayo so much cheaper?
Three reasons:
- Small molecule manufacturing: Unlike peptide-based GLP-1s (semaglutide, tirzepatide), orforglipron is a small molecule that can be manufactured using traditional pharmaceutical synthesis — far cheaper than biological/peptide production.
- Oral tablet form: No injection devices, no cartridges, no specialty packaging. A bottle of pills is dramatically cheaper to produce and distribute than pre-filled injection pens.
- Strategic pricing: Eli Lilly is pricing to capture market share from compounding pharmacies and position Foundayo as the accessible GLP-1 option.
Foundayo Savings Card: $25/Month
Eli Lilly offers the Foundayo Savings Card for commercially insured patients:
- Cost with savings card: $25/month
- Eligibility: Patients with commercial (private) insurance
- Not eligible: Government insurance (Medicare, Medicaid, Tricare, VA)
- How to get it: Register at Foundayo.com or ask your prescriber
The savings card covers the difference between your copay and $25. If your insurance copay is already $25 or less, the savings card won't provide additional benefit — but you're already in good shape.
Medicare Coverage: $50/Month
Starting July 1, 2026, Foundayo will be available for $50/month under Medicare Part D. Key details:
- The $50/month price is Eli Lilly's own pricing commitment, separate from the Medicare GLP-1 Bridge program
- The Medicare GLP-1 Bridge (July–December 2026) covers Wegovy and Zepbound for obesity at $50/month — Foundayo's $50 pricing is Lilly's independent program
- The permanent BALANCE Model for ongoing Medicare GLP-1 coverage begins January 2027 (not all Part D plans are required to participate)
For Medicare beneficiaries who've been watching GLP-1 medications from the sidelines due to cost, this represents a major shift. See our complete Medicare GLP-1 coverage guide for details on coverage nuances and eligibility.
Commercial Insurance Coverage
Coverage through commercial insurance varies by plan, but early data suggests strong formulary placement:
- Preferred brand tier: Many major insurers have placed Foundayo on preferred brand formularies given its lower list price
- Typical copays: $30–$75/month with insurance (before savings card)
- Prior authorization: Most plans require documentation of BMI ≥30 (or ≥27 with comorbidity) and a trial of lifestyle modification
- Step therapy: Some plans may require trying lower-cost options first, though Foundayo itself is often the lowest-cost branded GLP-1
Pro tip: Even if your initial claim is denied, appeal. Many denials are overturned on first appeal, especially with documentation from your provider about medical necessity.
How Foundayo Compares to Other GLP-1 Costs
| Medication | List Price/Month | Best Savings Price | Medicare (2026) |
|---|---|---|---|
| Foundayo | $149/mo (lowest dose); higher doses TBD | $25/mo (savings card) | $50/mo (Lilly commitment, July 2026) |
| Ozempic | ~$935 | $25/mo (savings card, diabetes) | Varies by plan |
| Wegovy | ~$1,349 | $25/mo (savings card) | Covered; cost varies |
| Zepbound | ~$1,086 | $499/mo (LillyDirect) | Covered; cost varies |
| Mounjaro | ~$1,023 | $25/mo (savings card, diabetes) | Varies by plan |
| Rybelsus | ~$935 | Savings card available | Varies by plan |
Even at list price, Foundayo is 75–88% cheaper than competing branded GLP-1 medications. With the savings card, it's competitive with or cheaper than the copays many patients pay for other GLP-1s with insurance.
Foundayo vs Compounded Semaglutide
Many patients have turned to compounding pharmacies for semaglutide at $150–$350/month. With the FDA crackdown on compounded semaglutide, Foundayo offers a legitimate, FDA-approved alternative at a comparable price point:
- Compounded semaglutide: $150–$350/month (503B bulk compounding banned since semaglutide is off the shortage list, but 503A patient-specific compounding remains legal in many states)
- Foundayo self-pay: $149/month at the lowest dose (higher doses cost more)
- Foundayo with savings card: $25/month
Unlike compounded versions, Foundayo comes with guaranteed potency, purity, FDA manufacturing oversight, and clinical trial data backing its safety and efficacy.
Tips to Minimize Your Cost
- Always check the savings card first. If you have commercial insurance, the $25/month savings card is almost certainly your best option.
- Ask about samples. Many prescribers have starter packs, especially during the first months after launch.
- Compare pharmacies. Prices can vary by $20–$50 between retail pharmacies. Use GoodRx or similar tools to price-shop.
- Consider mail-order. 90-day mail-order fills often offer per-month savings of 10–20%.
- Appeal insurance denials. First appeals succeed approximately 40–60% of the time. Ask your doctor's office to help with the paperwork.
- Check patient assistance programs. Eli Lilly's Lilly Cares program may provide Foundayo at no cost for patients who meet income requirements.
The Bottom Line
Foundayo has reset the pricing floor for branded GLP-1 medications. Whether you're paying out of pocket ($149–$249/month), using the savings card ($25/month), or on Medicare ($50/month starting July 2026), it's the most affordable branded option available. For the millions of Americans who've wanted to try a GLP-1 but couldn't justify the cost, Foundayo removes the financial barrier.
Sources
- Eli Lilly. Foundayo (orforglipron) Official Pricing. Foundayo.com. 2026.
- Centers for Medicare & Medicaid Services. 2026 Part D Formulary Updates.
- Eli Lilly. Foundayo Savings Card Program Details. 2026.
- Novo Nordisk. Ozempic/Wegovy WAC Pricing. 2026.
- Eli Lilly. Zepbound/Mounjaro WAC Pricing. 2026.